175 related articles for article (PubMed ID: 25850031)
1. Neuronal cell adhesion genes and antidepressant response in three independent samples.
Fabbri C; Crisafulli C; Gurwitz D; Stingl J; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Girolamo GD; Serretti A
Pharmacogenomics J; 2015 Dec; 15(6):538-48. PubMed ID: 25850031
[TBL] [Abstract][Full Text] [Related]
2. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.
Probst-Schendzielorz K; Scholl C; Efimkina O; Ersfeld E; Viviani R; Serretti A; Fabbri C; Gurwitz D; Lucae S; Ising M; Paul AM; Lehmann ML; Steffens M; Crisafulli C; Calabrò M; Holsboer F; Stingl J
Pharmacogenomics; 2015; 16(7):689-701. PubMed ID: 25943212
[TBL] [Abstract][Full Text] [Related]
3. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
4. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Sang-Hyuk L; Newhouse S; Patel H; Guipponi M; Perroud N; Bondolfi G; O'Donovan M; Lewis G; Biernacka JM; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Uher R; Lewis CM
Pharmacogenomics J; 2018 May; 18(3):413-421. PubMed ID: 29160301
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway.
Cocchi E; Fabbri C; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
BMC Psychiatry; 2016 Apr; 16():106. PubMed ID: 27091189
[TBL] [Abstract][Full Text] [Related]
6. PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway.
Fabbri C; Marsano A; Albani D; Chierchia A; Calati R; Drago A; Crisafulli C; Calabrò M; Kasper S; Lanzenberger R; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Pharmacogenomics J; 2014 Oct; 14(5):463-72. PubMed ID: 24709691
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.
Morag A; Pasmanik-Chor M; Oron-Karni V; Rehavi M; Stingl JC; Gurwitz D
Pharmacogenomics; 2011 Feb; 12(2):171-84. PubMed ID: 21332311
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
[TBL] [Abstract][Full Text] [Related]
9. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
[TBL] [Abstract][Full Text] [Related]
10. HTR2A gene variation is involved in antidepressant treatment response.
Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
[TBL] [Abstract][Full Text] [Related]
11. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide association study of a sustained pattern of antidepressant response.
Hunter AM; Leuchter AF; Power RA; Muthén B; McGrath PJ; Lewis CM; Cook IA; Garriock HA; McGuffin P; Uher R; Hamilton SP
J Psychiatr Res; 2013 Sep; 47(9):1157-65. PubMed ID: 23726668
[TBL] [Abstract][Full Text] [Related]
13. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Adhesion Molecule CHL1 in B Cells but Not T Cells of Patients with Major Depression and in the Brain of Mice with Chronic Stress.
Yang CR; Ning L; Zhou FH; Sun Q; Meng HP; Han Z; Liu Y; Huang W; Liu S; Li XH; Zheng B; Ming D; Zhou XF
Neurotox Res; 2020 Dec; 38(4):914-928. PubMed ID: 32557322
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics with antidepressants in the STAR*D study.
Lin E; Chen PS
Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
[TBL] [Abstract][Full Text] [Related]
16. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
[TBL] [Abstract][Full Text] [Related]
18. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
Adkins DE; Clark SL; Åberg K; Hettema JM; Bukszár J; McClay JL; Souza RP; van den Oord EJ
Transl Psychiatry; 2012 Jul; 2(7):e129. PubMed ID: 22760553
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.
Clark SL; Adkins DE; Aberg K; Hettema JM; McClay JL; Souza RP; van den Oord EJ
Psychol Med; 2012 Jun; 42(6):1151-62. PubMed ID: 22041458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
